EX-FILING FEES
Published on November 23, 2022
Exhibit 107
Calculation of Filing Fee Tables
FORM S-1
(Form Type)
Cellectar Biosciences, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security Type |
Security Class Title | Fee Calculation or Carry Forward Rule |
Amount Registered(1) |
Proposed Maximum Offering Price Per Share(2) |
Maximum Aggregate Offering Price(2) |
Fee Rate | Amount of Registration Fee |
|||||||||||||||||||||
| Fees to Be Paid | Equity | Common Stock, par value $0.00001 per share | 457 | (c) | 7,027,043 | $ | 1.88 | $ | 13,210,840.84 | 0.00011020 | $ | 1,455.84 | ||||||||||||||||
| (1) | Consists of an aggregate of 7,027,043 shares of the registrant’s common stock issuable upon the exercise of warrants, all of which were sold to the selling stockholders in private placements. Pursuant to Rule 416 under the Securities Act of 1933, as amended, the shares of common stock being registered hereunder include such indeterminate number of shares of common stock as may be issuable with respect to the shares of common stock being registered hereunder as a result of stock splits, stock dividends or similar transactions. | |
| (2) | Pursuant to Rule 457(c), calculated on the basis of the average of the high and low prices per share of common stock reported on The Nasdaq Capital Market on November 22, 2022. |